B-specific represented by HZDR team in May 2026, at conference and symposium in Germany

Alexandra von Jutrzenka-Trzebiatowski presented a poster entitled “Development of a RevCAR T cell platform for precise and personalized targeting of cardiovascular disorders” at the TIMO (Tumor Immunology Meets Oncology) conference held between 7th- 9th of May 2026 in Brandenburg an der Havel, and gave a speed talk and presented a poster with the topic “CARs beyond cancer: Developing a precision therapy for cardiovascular diseases using an adapter CAR T approach” at the DZG symposium in Dresden, held on the 11th May 2026.

Funded by the European Union under Grant Agreement No. 101115159.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Innovation Council and SMEs Executive Agency (EISMEA). Neither the European Union nor the granting authority can be held responsible for them.